Acetylcarnitine

Acetylcarnitine

SCHEMBL948558

CC(=O)OC(CC(=O)[O-])C[N+](C)(C)C.N=C(N)NCCC[C@H](N)C(=O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACE

The experimentally established mechanism targets of Acetylcarnitine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.56
▸ KMT2A Q03164 3/20 0.56
▸ CYP1A2 P05177 1/20 0.56
▸ HRH1 P35367 1/20 0.56
▸ LMNA P02545 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ CYP2C19 P33261 2/20 0.42
▸ RECQL P46063 1/20 0.42
▸ SLC25A20 O43772 3/20 0.40
▸ TP53 P04637 2/20 0.40
▸ CYP2D6 P10635 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ SLC6A5 Q9Y345 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ THPO P40225 1/20 0.40
▸ HIF1A Q16665 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetylcarnitine SCHEMBL27934793 0.99 MEN1 (0.55) MEN1KMT2ACYP1A2HRH1LMNA
Acetylcarnitine SCHEMBL620955 0.99 MEN1 (0.55) MEN1KMT2ACYP1A2HRH1LMNA
SCHEMBL15549471 0.86 MEN1 (0.48) MEN1KMT2ACYP1A2HRH1CYP2C19
Arginine SCHEMBL27902011 0.84 SLC22A16 (0.50) MEN1KMT2ACYP2C19MAPTCPT2
Arginine SCHEMBL27492468 0.83 SLC22A16 (0.49) MEN1KMT2ACYP2C19MAPTCPT2
Acetylcarnitine SCHEMBL5429939 0.82 MEN1 (0.65) MEN1KMT2ACYP1A2HRH1LMNA
Acetylcarnitine SCHEMBL2322756 0.82 MEN1 (0.65) MEN1KMT2ACYP1A2HRH1LMNA
Acetylcarnitine SCHEMBL5429930 0.82 MEN1 (0.65) MEN1KMT2ACYP1A2HRH1LMNA
Acetylcarnitine SCHEMBL6634470 0.81 KMT2A (0.63) MEN1KMT2ACYP1A2HRH1LMNA
Acetylcarnitine SCHEMBL6634467 0.81 KMT2A (0.63) MEN1KMT2ACYP1A2HRH1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8349376-B1 Anti-dementia regimen BEZZEK MARK S (US) 2013-01-08 — — US claimed
US-8343517-B1 Multivitamin-mineral longevity regimen BEZZEK MARK S (US) 2013-01-01 — — US claimed
US-20190175610-A1 FORMULATION OF GALANTAMINE AND CARNITINE AND METHOD OF FATTY ACID MOBILIZATION GLYKON TECHNOLOGIES GROUP, LLC (US) 2019-06-13 — — US disclosed
CN-103200827-B For keeping fit and treating the lipid replenishers of acute and chronic disease Allergy Research Group Co.,Ltd. (US) 2016-05-18 — — CN disclosed
US-9167839-B1 Multivitamin-mineral regimens for longevity and wellness BEZZEK MARK S (US) 2015-10-27 — — US disclosed
US-9167839-B1 Multivitamin-mineral regimens for longevity and wellness BEZZEK MARK S (US) 2015-10-27 — — US disclosed
US-9161565-B1 Multivitamin-mineral regimens for longevity and wellness BEZZEK MARK S (US) 2015-10-20 — — US disclosed
US-9161565-B1 Multivitamin-mineral regimens for longevity and wellness BEZZEK MARK S (US) 2015-10-20 — — US disclosed
US-8846061-B1 Multivitamin-mineral regimens for longevity and wellness BEZZEK MARK S (US) 2014-09-30 — — US disclosed
US-8846061-B1 Multivitamin-mineral regimens for longevity and wellness BEZZEK MARK S (US) 2014-09-30 — — US disclosed
US-8343517-B1 Multivitamin-mineral longevity regimen BEZZEK MARK S (US) 2013-01-01 — — US disclosed
US-20110015154-A1 SUPPORTING ACETYLCHOLINE FUNCTION NEUROSCIENCE, INC. 2011-01-20 — — US disclosed
Send feedback